RE:well..I am hoping we never hear anything from him because he's always too busy negotiating partnerships or reading over term sheets for buyouts. But even if he's not dma has an extremely competent team with most, if not all, actually been involved in the Pharma/biotech world with decades of combined experience. They even have a big wheel from China on the board. Now what do these guys do all day? Are they all involved in planning the next phase study? Are they all relying on third party groups to promote the stock for them, ie Zacks and others? Again, not sure about this either but the fact is we have so many pieces of the puzzle but the order is somehow out of place. Not sure what the solution is but the pathetic performance of the stock is really starting to get old. I barely even look at it anymore because the 30cents and under game got so so old.